We are live on ! Find out more
ELTX icon

Elicio Therapeutics
ELTX

24 hedge funds and large institutions have $9.8M invested in Elicio Therapeutics in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

335% more capital invested

Capital invested by funds: $2.25M → $9.8M (+$7.55M)

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

41% more funds holding

Funds holding: 17 → 24 (+7)

5.83% more ownership

Funds ownership: 4.21% → 10.04% (+5.8%)

Holders
24
Holders Change
+7
Holders Change %
+41.18%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
+$4.89M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$1.42M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$588K
4
Millennium Management
Millennium Management
New York
+$404K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$283K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$3.12K
2
State Street
State Street
Massachusetts
-$2.32K
3
Citigroup
Citigroup
New York
-$1.83K
4
JP Morgan Chase
JP Morgan Chase
New York
-$15
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$3.89M +$4.89M +630,915 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.98M +$588K +75,871 +31%
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$1.13M +$1.42M +182,734 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$477K +$52.3K +6,746 +10%
CM
5
CM Management
Florida
$339K +$116K +15,000 +38%
Millennium Management
6
Millennium Management
New York
$322K +$404K +52,218 New
Northern Trust
7
Northern Trust
Illinois
$319K +$163K +21,086 +69%
BlackRock
8
BlackRock
New York
$242K +$151K +19,512 +98%
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$225K +$283K +36,537 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$193K +$243K +31,361 New
State Street
11
State Street
Massachusetts
$133K -$2.32K -300 -1%
UBS Group
12
UBS Group
Switzerland
$131K +$164K +21,181 +124,594%
QCM
13
Quantinno Capital Management
New York
$123K +$155K +20,000 New
Jane Street
14
Jane Street
New York
$92.4K +$116K +14,993 New
MHC
15
Meyer Handelman Company
New York
$85.6K – – –
MLL
16
Moody Lynn & Lieberson
Massachusetts
$61.6K +$77.5K +10,000 New
CIBC Private Wealth Group
17
CIBC Private Wealth Group
Georgia
$42.6K – – –
SPIA
18
Steward Partners Investment Advisory
New York
$9.57K – – –
Bank of America
19
Bank of America
North Carolina
$7.42K +$62 +8 +0.7%
Morgan Stanley
20
Morgan Stanley
New York
$5.19K +$4.74K +612 +266%
Fidelity Investments
21
Fidelity Investments
Massachusetts
$1.14K +$1.43K +185 New
SS
22
SBI Securities
Japan
$511 – – –
BNP Paribas Financial Markets
23
BNP Paribas Financial Markets
France
$400 – – –
JP Morgan Chase
24
JP Morgan Chase
New York
$99 -$15 -2 -11%
TRCT
25
Tower Research Capital (TRC)
New York
– -$3.12K -611 Closed
1
2

ELTX Hedge Fund Activity: Q1 2025 in Review

24 of the 7,464 institutional investors tracked by Wall St. Rank reported a position in Elicio Therapeutics (ELTX) for Q1 2025, worth a combined $9.8M — up 335% from $2.25M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ELTX positions and 2 closed out — a net gain of 7 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Knoll Capital Management, opening a new position worth an estimated $4.89M. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $3.12K sold.

  • 24 institutional investors held Elicio Therapeutics (ELTX) as of Q1 2025, up from 17 in Q4 2024.
  • Funds reported $9.8M of Elicio Therapeutics stock for Q1 2025, up 335% quarter-over-quarter.
  • 9 funds opened new Elicio Therapeutics positions in Q1 2025 and 2 closed out, a net change of +7 holders.
  • The largest Elicio Therapeutics buyer in Q1 2025 was Knoll Capital Management, an estimated $4.89M added.
  • The largest Elicio Therapeutics seller in Q1 2025 was Tower Research Capital (TRC), an estimated $3.12K sold.

Based on aggregated 13F filings for Q1 2025.